TARS Form 144: Proposed sale of 11,964 vested shares

TARS filed a Form 144 reporting proposed sales tied to recently vested restricted common stock and recent dispositions by an insider.

Accepted by SEC EDGAR 03/19/2026 - 04:30 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

TARS filed a Form 144 reporting proposed sales tied to recently vested restricted common stock and recent dispositions by an insider. The filing lists 11,964 shares associated with restricted stock vesting on 03/18/2026 and shows prior sales by Bobak Azamian of 10,972 shares on 03/17/2026 and 11,667 shares on 03/18/2026, with dollar amounts shown alongside each sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the TARS Form 144 disclose about the shares to be sold?

The filing discloses 11,964 common shares tied to restricted stock vesting on 03/18/2026. It identifies the transaction type as compensation (restricted stock vesting) and lists a broker/dealer record for the position.

Who reported recent sales in the TARS Form 144 and how many shares were sold?

The filing shows recent dispositions by Bobak Azamian: 10,972 shares sold on 03/17/2026 and 11,667 shares sold on 03/18/2026, with corresponding dollar figures reported alongside each trade.

Are the dollar amounts for the reported sales included in the TARS Form 144?

Yes. The filing lists sale proceeds alongside each disposition: $761,618.09 for the 10,972-share sale and $801,637.24 for the 11,667-share sale, as reported in the transaction lines.

Was a broker or brokerage account identified in the TARS Form 144?

The filing references Fidelity Brokerage Services LLC with an address and includes a record of 11,964 shares (listed near the broker line) and a NASDAQ designation, indicating the broker/dealer handling the shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001827672
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Tarsus Pharmaceuticals, Inc.
SEC File Number	001-39614
Address of Issuer	15440 LAGUNA CANYON ROAD IRVINE CALIFORNIA 92618
Phone	(949) 409-9820
Name of Person for Whose Account the Securities are To Be Sold	Azamian Bobak R.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	11964	801573.64	42557492	03/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2026	Restricted Stock Vesting	Issuer			11964	03/18/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Bobak Azamian 15440 Laguna Canyon Road Suite 160 Irvine CA 92618	Common	03/17/2026	10972	761618.09
Bobak Azamian 15440 Laguna Canyon Road Suite 160 Irvine CA 92618	Common	03/18/2026	11667	801637.24

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	03/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Adam Gehring, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Bobak Azamian
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)